DEVELOPMENT OF INNOVATIVE INTERVENTIONS FOR HEALTHY AGEING: HOW FAR DID WE GET?

Track:
Development of Medicinal Products for Paediatric, Elderly and other

Day & Time:
March 5, 2:00PM - 3:30PM

Session Number:
0203

Room Number:
Emerald Room

Level:
Intermediate

Type:
Session

Title:
DEVELOPMENT OF INNOVATIVE INTERVENTIONS FOR HEALTHY AGEING: HOW FAR DID WE GET?

Chair(s):
Susanna Del Signore, MD
Associate Vice President, Global Regulatory Affairs
Sanofi, France

Description:
One year after the call for European Innovation Partnership on Healthy and Active Ageing by the European Commission, one ongoing programme will be presented by its respective Partnership representative and subsequently discussed. The main objectives, intervention outlines and identified bottlenecks (e.g. methodology, business model, and regulatory aspects) will be opened to discussion. This will focus on actual expected benefits for older people and industrial sustainability of the innovative interventions.

Learning Objective(s):
Secondary Prevention of Geriatric conditions Physical Frailty as an example of geriatric condition Compliance and Adherence as a therapeutic target Health Literacy and Awareness of geriatric conditions